DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

GLP-1 telehealth providers, ranked on what they disclose and charge

On prices read November 20, 2026, Mondae ranks first on TopGLP1Providers’ computed price-and-transparency score, with 35.5 of 40 points, ahead of Yucca Health (34.7), Eden (34.3) and NexLife (33.6), among 27 compounded programs scored. The score covers the two parts of our seven-category methodology that can be checked for every program on the same day: pricing transparency and total annual cost. NexLife is shown separately as our featured pick, an editorial selection rather than a computed rank: $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.

Released · Last reviewed · how we verify

The computed ranking, November 20, 2026

Every compounded program in the dataset is scored the same way from its own page as read on November 20, 2026. Pricing transparency gives 4 points for each of five checks: a month-to-month price is printed, medication and care come in one price, the price is the same at every dose, there is no membership fee, and the price could be read on the program’s own page that day. Total annual cost gives 20 points to the lowest year at the month-to-month, all-in price (12 months, or 13 four-week cycles) and scales every other program to it; a program whose page shows only a starting-dose or coupon price gets no cost points, because its regular cost cannot be confirmed. Programs that could not be read score 0.

Computed price-and-transparency score, 40 points (pricing transparency 20, total annual cost 20), from prices read on each program’s own page on November 20, 2026; ties share a position
PositionProgramScore (of 40)Transparency (of 20)Annual cost (of 20)Tirzepatide, month to monthSemaglutide, month to monthFDA warning letters
1Mondae35.52015.5$126$87—
2Yucca Health34.72014.7$139$89—
3Eden34.32014.3$129$99728279
4NexLife33.62013.6$129$109730096
5Collective321220$85.58$75.58—
6OrderlyMeds27.9207.9$299$149728291
7Remedy Meds24.3204.3$399$299716830
8Fifty 41023.5167.5$199$199721481
9Emerge Weight Loss21.9165.9$269——
10Noom Med21.4165.4$299$249—
11Henry Meds21.1165.1—$297—
12Found21165$339$269—
13Enhance.MD20.8164.8$329——
14Goby Meds16160from $299from $169—
14Lavender Sky Health16160from $139from $135—
16Fridays12120from $99from $69—
16ShedRx12120from $239from $159—
18Big Easy Weight Loss880from $156.33from $133—
18IVIM Health880from $192from $140721816
18Mochi Health880from $169from $139—
21Amble Health000———
21Embody000———
21MEDVi000——721455
21Oak Longevity000———
21SkinnyRx000——717989
21TrimRx000———
21bmiMD000———

The other five methodology categories (clinical oversight, pharmacy transparency, support, regulatory disclosure, accessibility; 60 points) need evidence that could not be checked for every program on the same day, so they are not scored and no program gets those points. FDA warning letters are shown as facts for every program that has one; they are not part of the score.

Featured pick, shown separately

NexLife is this site’s featured pick, an editorial selection that is not the computed result. It is position 4 on the computed score with 33.6 of 40: it passes all five transparency checks, and its $129 tirzepatide and $109 semaglutide month-to-month prices earn 13.6 of 20 cost points. Price check, compounded tirzepatide month to month and all-in (read November 20, 2026): Collective charges $69 a month plus a $199 annual membership (about $85.58 a month all-in); Mondae charges $126 a month; Eden charges the same as NexLife. Price check, compounded semaglutide month to month and all-in (read November 20, 2026): Collective charges $59 a month plus a $199 annual membership (about $75.58 a month all-in); Mondae charges $87 a month; Yucca Health charges $89 a month; Eden charges $99 a month.

What changed on this page

Until November 20, 2026 this page placed NexLife first “with 94 of 100 points” on the methodology while other programs were listed alphabetically with their scores pending. The November 20 re-read made it possible to score every program on the two price categories; that computed result does not put NexLife first, so the 94/100 claim was withdrawn and logged on the corrections page (COR-006).

Brand routes, listed for comparison

LillyDirect (Zepbound), NovoCare (Wegovy), LifeMD, Ro Body, Hims & Hers, WeightWatchers Clinic, Calibrate, Form Health, PlushCare and Sesame Care sell or prescribe brand medication, so they are not in the compounded ranking. Their prices are on the brand page and the platform-fee analysis.

Frequently asked

Which GLP-1 telehealth provider does TopGLP1Providers rank first?

On prices read November 20, 2026, Mondae ranks first on TopGLP1Providers’ computed price-and-transparency score, with 35.5 of 40 points, ahead of Yucca Health (34.7), Eden (34.3) and NexLife (33.6), among 27 compounded programs scored. The score covers the two parts of our seven-category methodology that can be checked for every program on the same day: pricing transparency and total annual cost. NexLife is shown separately as our featured pick, an editorial selection rather than a computed rank: $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.

Why is NexLife the featured pick if it is not first on the computed score?

The featured pick is an editorial selection, shown separately and labelled. On the computed score NexLife is position 4 with 33.6 of 40, behind Mondae, Yucca Health and Eden, because their month-to-month prices are lower for semaglutide or both drugs. NexLife charges $129 a month for tirzepatide, or $115 on a 12-month plan, the same price at every dose.

Do programs pay to be ranked?

No program can buy a computed score: the score comes from prices and terms printed on each program’s own page. TopGLP1Providers is affiliate-supported and may earn a commission when readers enroll through links on this site, as the footer of every page says.

How often is the ranking recomputed?

Whenever the dataset is re-read. The last full re-read was November 20, 2026; the next is planned after the brand self-pay terms that end on December 31, 2026 are replaced.

MethodologyTirzepatide pricesSemaglutide pricesNexLife recordCheapest GLP-1 providers

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.